+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunotherapy"

Oncolytic Virus Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virus Immunotherapy - Global Strategic Business Report

  • Report
  • October 2025
  • 383 Pages
  • Global
From
Ewing Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Ewing Sarcoma - Global Strategic Business Report

  • Report
  • October 2025
  • 377 Pages
  • Global
From
Autoimmune Drugs - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 287 Pages
  • Global
From
Allergy Vaccines - Global Strategic Business Report - Product Thumbnail Image

Allergy Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 481 Pages
  • Global
From
From
Angiosarcoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Angiosarcoma Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 390 Pages
  • Global
From
From
From
From
Hyperthermia Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Hyperthermia Cancer Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 384 Pages
  • Global
From
From
Oncolytic Virus Therapy - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virus Therapy - Global Strategic Business Report

  • Report
  • October 2025
  • 483 Pages
  • Global
From
Antibody Fragments - Global Strategic Business Report - Product Thumbnail Image

Antibody Fragments - Global Strategic Business Report

  • Report
  • October 2025
  • 176 Pages
  • Global
From
Retinoblastoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Retinoblastoma Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 279 Pages
  • Global
From
Stomach Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Stomach Cancer Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 371 Pages
  • Global
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 380 Pages
  • Global
From
Celiac Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Celiac Disease Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 371 Pages
  • Global
From
Cancer Treatment Facilities - Global Strategic Business Report - Product Thumbnail Image

Cancer Treatment Facilities - Global Strategic Business Report

  • Report
  • October 2025
  • 382 Pages
  • Global
From
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • October 2025
  • 211 Pages
  • Global
From
Loading Indicator

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis. Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life. The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more